Prudential plc’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.55M Sell
7,696
-133
-2% -$45.3K 0.01% 363
2025
Q4
$3.11M Buy
7,829
+133
+2% +$58.9K 0.02% 334
2025
Q3
$3.51M Buy
7,696
+3,584
+87% +$1.46M 0.03% 327
2025
Q2
$1.34M Buy
4,112
+2,065
+101% +$571K 0.01% 458
2025
Q1
$553K Sell
2,047
-2,233
-52% -$574K ﹤0.01% 573
2024
Q4
$1.01M Buy
4,280
+1,264
+42% +$332K 0.01% 510
2024
Q3
$829K Buy
3,016
+143
+5% +$37.2K ﹤0.01% 549
2024
Q2
$698K Hold
2,873
﹤0.01% 539
2024
Q1
$429K Sell
2,873
-1,994
-41% -$333K ﹤0.01% 621
2023
Q4
$932K Sell
4,867
-11
-0.2% -$1.87K 0.01% 601
2023
Q3
$864K Sell
4,878
-761
-13% -$145K 0.01% 570
2023
Q2
$1.07M Sell
5,639
-81
-1% -$16.1K 0.01% 552
2023
Q1
$1.15M Buy
5,720
+6
+0.1% +$1.26K 0.01% 513
2022
Q4
$1.36M Buy
5,714
+3,617
+172% +$771K 0.02% 462
2022
Q3
$420K Buy
2,097
+316
+18% +$60.3K 0.01% 628
2022
Q2
$260K Hold
1,781
﹤0.01% 734
2022
Q1
$291K Buy
+1,781
New +$271K ﹤0.01% 736

Other funds holding ALNY